Aquestive Therapeutics Signs Exclusive Libervant License With Eton

Aquestive Therapeutics shares rose in premarket trading Oct. 14 after the company granted Eton Pharmaceuticals an exclusive license covering Libervant, its diazepam buccal film for treating seizures. The agreement concerns an anti-seizure medication delivered as a film placed inside the cheek. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.